Researchers use light to measure cancer cells' response to treatment

December 20, 2011

Many cancer therapies target specific proteins that proliferate on the outside of some cancer cells, but the therapies are imperfect and the cancer does not always respond. Since it is beneficial for doctors to know as soon as possible how a cancer is affected by treatment, researchers from Vanderbilt University are striving to design tests that assess treatment response rapidly, accurately, and cost-effectively. The team has demonstrated a new way to optically test cultured cancer cells' response to a particular cancer drug. The results appear in the December issue of the Optical Society's (OSA) open-access journal Biomedical Optics Express.

Certain cancer cells display a higher-than-normal number of proteins called human 2 (HER2). In healthy cells, HER2 helps mediate cell growth, but overexpression of HER2 can mark one of the most aggressive forms of breast cancer. Drugs that bind to and block have been shown to prolong life in some cancer patients, but about 30 percent of HER2 overexpressing tumors do not respond to the drug. Tests to identify these non-responding tumors early on would help doctors make important treatment decisions that could improve patient outcomes.

To design such a test, the Vanderbilt team took advantage of the fact that some cancer cells preferentially use a different when compared to normal cells. The researchers visualized the relative use of the different pathways by shining the cells with frequencies of light that caused two different metabolic molecules to naturally fluoresce. They then calculated a ratio between the two levels of fluorescence, called an optical redox ratio. The team found that, of the different cell lines they tested, HER2 overexpressing cells had the highest optical redox ratio. They also found that when HER2 cancer cells were treated with an HER2-blocking drug, the ratio decreased. This decrease, however, was not observed in that were resistant to the drug. The findings lay the groundwork for future in vivo studies and hold the promise that real-time tumor response to treatment might be measured optically.

Explore further: Herceptin targets breast cancer stem cells

More information: Paper: "Optical imaging of metabolism in HER2 overexpressing breast cancer cells," Biomedical Optics Express, Vol. 3, Issue 1, pp. 75-85 (2012).

Related Stories

Herceptin targets breast cancer stem cells

July 9, 2008

A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive ...

HOXB7 gene promotes tamoxifen resistance

December 11, 2010

Many postmenopausal women with early-stage breast cancers who initially respond well to tamoxifen become resistant to the drug over time and develop recurrent tumors. Johns Hopkins Kimmel Cancer Center researchers have found ...

New therapy for HER2-positive breast cancer developed

July 26, 2011

Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.

Recommended for you

Chemists explore outer regions of periodic table

August 25, 2016

A little known—and difficult to obtain—element on the fringes of the periodic table is broadening our fundamental understanding of chemistry. In the latest edition of the journal Science, Florida State University Professor ...

Measuring tiny forces with light

August 25, 2016

Photons are bizarre: They have no mass, but they do have momentum. And that allows researchers to do counterintuitive things with photons, such as using light to push matter around.

DNA chip offers big possibilities in cell studies

August 25, 2016

A UT Dallas physicist has developed a novel technology that not only sheds light on basic cell biology, but also could aid in the development of more effective cancer treatments or early diagnosis of disease.

Understanding nature's patterns with plasmas

August 23, 2016

Patterns abound in nature, from zebra stripes and leopard spots to honeycombs and bands of clouds. Somehow, these patterns form and organize all by themselves. To better understand how, researchers have now created a new ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.